Open official notice

Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg 6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count

Official notice

10 Dec 2025

RecallScope risk estimate:MediumFDA

An official FDA notice concerns Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg 6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count. Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe Published 2025-12-10.

What to do now

Do not consume or use the affected product. Return it to the place of purchase or follow instructions in the official FDA notice.

Units affected

11,136

Recall number

D-0199-2026

Official notice

2025-12-10

The hazard

Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

17232401, 17240974

Event Ids

98036

Recall Numbers

D-0199-2026

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, Inda. Manufactured for: Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430.

Units affected

11,136

Hazard

Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Glenmark Pharmaceuticals Inc., USA

Phone

Not provided

Brand: Glenmark Pharmaceuticals. Contact: Glenmark Pharmaceuticals Inc., USA.

Source & status

Source

Tier

official

Category

Health

Official classification

Class III

Recall details

Recall number

D-0199-2026

Event ID

98036

Units affected

11,136

Status

active

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 10 Dec 2025. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button